GRAZI, Gian Luca
 Distribuzione geografica
Continente #
AS - Asia 3.354
NA - Nord America 3.199
SA - Sud America 1.085
EU - Europa 875
AF - Africa 77
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.598
Nazione #
US - Stati Uniti d'America 3.074
SG - Singapore 1.667
BR - Brasile 887
HK - Hong Kong 520
CN - Cina 468
VN - Vietnam 363
RU - Federazione Russa 192
IT - Italia 184
ID - Indonesia 161
DE - Germania 134
GB - Regno Unito 104
MX - Messico 76
AR - Argentina 70
UA - Ucraina 49
AT - Austria 44
EC - Ecuador 42
NL - Olanda 39
FI - Finlandia 36
ZA - Sudafrica 34
CO - Colombia 32
TR - Turchia 30
IN - India 29
BD - Bangladesh 26
SE - Svezia 24
PY - Paraguay 23
CA - Canada 22
FR - Francia 21
IQ - Iraq 16
CL - Cile 10
JP - Giappone 9
KE - Kenya 9
DO - Repubblica Dominicana 8
ES - Italia 8
MA - Marocco 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
VE - Venezuela 7
IE - Irlanda 6
JM - Giamaica 6
PK - Pakistan 6
TN - Tunisia 6
DZ - Algeria 5
KR - Corea 5
PE - Perù 5
PL - Polonia 5
UY - Uruguay 5
BO - Bolivia 4
JO - Giordania 4
KZ - Kazakistan 4
LT - Lituania 4
TW - Taiwan 4
BY - Bielorussia 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
SA - Arabia Saudita 3
AM - Armenia 2
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
NP - Nepal 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CD - Congo 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
Totale 8.592
Città #
Singapore 735
Santa Clara 707
Hong Kong 520
Fairfield 273
Ashburn 250
Beijing 226
Chandler 165
Ho Chi Minh City 131
Jakarta 130
Woodbridge 103
Houston 94
Hanoi 82
Princeton 72
Seattle 72
Wilmington 72
São Paulo 70
Mexico City 62
Cambridge 58
Moscow 55
Dallas 45
Chicago 43
San Diego 42
Ann Arbor 40
Nuremberg 40
London 35
Helsinki 30
Los Angeles 29
Rio de Janeiro 29
Shanghai 28
Salt Lake City 23
Jacksonville 21
Rome 20
Vienna 20
Belo Horizonte 17
Curitiba 17
Falkenstein 16
Falls Church 16
Porto Alegre 16
Portsmouth 16
Quito 16
Biên Hòa 15
Guangzhou 15
Haiphong 15
Ferrara 14
Brasília 13
Lauterbourg 12
Milan 12
Bologna 11
Da Nang 11
Guarulhos 11
Guayaquil 11
Medellín 11
New York 11
Baghdad 10
Fortaleza 10
Hangzhou 10
Campinas 9
Juiz de Fora 9
St Petersburg 9
Asunción 8
Brooklyn 8
Hải Dương 8
Salvador 8
Tampa 8
Tashkent 8
Xian 8
Baku 7
Can Tho 7
Dhaka 7
Duque de Caxias 7
Düsseldorf 7
Hounslow 7
Kilburn 7
Manaus 7
Montreal 7
Osasco 7
Ribeirão Preto 7
Ankara 6
Buenos Aires 6
Bắc Giang 6
Carapicuíba 6
Frankfurt am Main 6
Johannesburg 6
Lubbock 6
Mountain View 6
Nairobi 6
Norwalk 6
Phủ Lý 6
Redwood City 6
Sorocaba 6
Sterling 6
Stockholm 6
São Bernardo do Campo 6
São José dos Campos 6
Tokyo 6
Vicenza 6
Bari 5
Cabo Frio 5
Canoas 5
Cape Town 5
Totale 4.922
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 176
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 140
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 139
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 119
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 106
The Immune Landscape of Cancer 101
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 99
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 91
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 87
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 86
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 82
Oncogenic Signaling Pathways in The Cancer Genome Atlas 81
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 81
Comprehensive Characterization of Cancer Driver Genes and Mutations 79
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 75
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 73
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 70
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 69
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 69
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 68
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 68
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 68
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 68
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 67
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 67
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 66
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 66
ALPPS for primary and secondary liver tumors 66
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 66
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 64
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 63
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 62
Primary leiomyoma of the liver in an immunocompetent patient 61
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 61
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 60
Pathogenic Germline Variants in 10,389 Adult Cancers 60
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 59
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 58
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 58
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 58
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 58
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 57
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 55
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 55
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 55
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 55
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 55
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 54
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 54
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 54
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 53
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 53
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 52
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 52
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 52
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 51
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 51
Outcome of Right Hepatectomies in Patients Older Than 70 Years 51
Is it time to develop a robotic difficulty score system? 51
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 50
Multicentre evaluation of case volume in minimally invasive hepatectomy 50
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 50
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 50
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 50
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 50
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 49
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 49
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 49
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 49
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 49
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 49
The peculiar aging of human liver: A geroscience perspective within transplant context 49
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 48
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 48
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 48
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 47
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 47
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 46
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach 46
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 46
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 45
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 45
A room for the alpps procedure in patients with HCC 45
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 45
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 45
Coping strategies in intestinal transplantation 44
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience 44
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 43
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine 43
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 43
Modified outflow reconstruction with a venous patch in domino liver transplantation 42
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 42
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus 42
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? 42
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 42
Efficacy of MELD score in predicting survival after liver retransplantation 41
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 41
Technical feasibility and short-term outcomes of laparoscopic isolated caudate lobe resection: an IgoMILS (Italian Group of Minimally Invasive Liver Surgery) registry-based study 41
Kidney transplantation combined with other organs: experience of Bologna S. Orsola hospital 40
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically 40
Totale 6.049
Categoria #
all - tutte 102.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 9 5 0 65 109 31 110 25
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023797 75 45 8 50 46 397 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.195 115 49 326 3 376 392 58 129 402 836 238 271
2025/20263.350 467 344 852 1.009 678 0 0 0 0 0 0 0
Totale 9.115